|
| N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide Basic information |
Product Name: | N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide | Synonyms: | N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide;VU 0255035;N-(3-Oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo[c][1,2,5]thiadiazole-4-sulfonaMide;CID24768606;ML012;N-(3-oxo-3-(4-(pyridine-4-yl)piperazin-1-yl)propyl)benzo[c][1,2,5]thiadiazole-4-sulfonamide hydrate;N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide hydrate;VU0255035 hydrate | CAS: | 1135243-19-4 | MF: | C18H20N6O3S2 | MW: | 432.52 | EINECS: | | Product Categories: | | Mol File: | 1135243-19-4.mol | |
| N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide Chemical Properties |
Melting point | 159.7-160.2 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3)) | Boiling point | 689.3±65.0 °C(Predicted) | density | 1.447±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: >5mg/mL | form | powder | pka | 8.97±0.50(Predicted) | color | yellow |
Hazard Codes | Xn | Risk Statements | 22-36/37/38 | Safety Statements | 26 | WGK Germany | 3 |
| N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide Usage And Synthesis |
Uses | VU 0255035 is a novel, selective antagonist of M1 mAChRs, which has potential treatment in CNS disorders. | Definition | ChEBI: N-[3-oxo-3-(4-pyridin-4-yl-1-piperazinyl)propyl]-2,1,3-benzothiadiazole-4-sulfonamide is a member of pyridines and a member of piperazines. | storage | Store at -20°C |
| N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide Preparation Products And Raw materials |
|